Cargando…
Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
Sepsis is a complex condition that results from a dysregulated immune system in response to a systemic infection. Current treatments lack effectiveness in reducing the incidence and mortality associated with this disease. The endocannabinoid system offers great promise in managing sepsis pathogenesi...
Autores principales: | Sardinha, J., Kelly, M. E. M., Zhou, J., Lehmann, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997158/ https://www.ncbi.nlm.nih.gov/pubmed/24803745 http://dx.doi.org/10.1155/2014/978678 |
Ejemplares similares
-
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis
por: Lehmann, Christian, et al.
Publicado: (2012) -
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice
por: Gui, Huan, et al.
Publicado: (2013) -
Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice
por: Berger, Geraint, et al.
Publicado: (2019) -
Cannabinoid 2 receptor antagonism reverses central nervous system injury-induced immune deficiency syndrome
por: Burkovskiy, IB, et al.
Publicado: (2015) -
Impact of modulation of the endocannabinoid system on the intestinal microcirculation in experimental sepsis
por: Lehmann, C, et al.
Publicado: (2011)